Evidence map›Paper›PMID 17474905›Full record

ArticleCellular microbiology2007

Inactivation of small Rho GTPases by the multifunctional RTX toxin from Vibrio cholerae.

Kerri-Lynn Sheahan, Karla J Fullner Satchell

Open access · bronzeAbstract read
In one paragraph

Article in Cellular microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 72 citations in OpenAlex.

  1. Chemical Proteomics Reveals NMolecular & cellular proteomics : MCP · 2024
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. TheScience signaling · 2020
    Article
  7. Article
  8. El Tor BiotypeFrontiers in immunology · 2019
    Article
  9. Emerging microbes & infections · 2019
    Article
  10. Review
  11. NNature microbiology · 2018
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Kerri-Lynn SheahanDepartment of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Karla J Fullner Satchell
Bipar · FRNorthwestern University · US

Funding

TRAINING PROGRAM IN IMMUNOLOGY &MOLECULAR PATHOGENESIST32AI007476 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Edward Benjamin Thorp · 1996 to 2026
$6.6M
Genetic and biochemical study ov V. cholerase RTX toxinR01AI051490 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SATCHELL, KARLA J F · 2003 to 2012
$3.3M
NIAID NIH HHS AI 51490NIAID NIH HHS R01 AI051490NIAID NIH HHS T32 AI007476NIAID NIH HHS T32 AI 07476
6 · The paper itself

Abstract

Many bacterial toxins target small Rho GTPases in order to manipulate the actin cytoskeleton. The depolymerization of the actin cytoskeleton by the Vibrio cholerae RTX toxin was previously identified to be due to the unique mechanism of covalent actin cross-linking. However, identification and subsequent deletion of the actin cross-linking domain within the RTX toxin revealed that this toxin has an additional cell rounding activity. In this study, we identified that the multifunctional RTX toxin also disrupts the actin cytoskeleton by causing the inactivation of small Rho GTPases, Rho, Rac and Cdc42. Inactivation of Rho by RTX was reversible in the presence of cycloheximide and by treatment of cells with CNF1 to constitutively activate Rho. These data suggest that RTX targets Rho GTPase regulation rather than affecting Rho GTPase directly. A novel 548-amino-acid region of RTX was identified to be responsible for the toxin-induced inactivation of the Rho GTPases. This domain did not carry GAP or phosphatase activities. Overall, these data show that the RTX toxin reversibly inactivates Rho GTPases by a mechanism distinct from other Rho-modifying bacterial toxins.

Indexed as

ActinsBacterial ToxinsBlotting, Westerncdc42 GTP-Binding ProteinCell Line, TumorCycloheximideCytoskeletonEnzyme ActivationEscherichia coli ProteinsGreen Fluorescent ProteinsGTPase-Activating ProteinsHumansMicroscopy, FluorescenceMicroscopy, Phase-ContrastMonomeric GTP-Binding ProteinsPhosphoric Monoester HydrolasesActinsBacterial Toxinscdc42 GTP-Binding ProteinCycloheximidecytotoxic necrotizing factor type 1Escherichia coli ProteinsGreen Fluorescent ProteinsGTPase-Activating ProteinsMonomeric GTP-Binding ProteinsPhosphoric Monoester Hydrolasesrac GTP-Binding Proteinsrho GTP-Binding Proteins

Identifiers

PMID17474905
PMCPMC2258554
OpenAlexW2066110317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.